News | September 27, 2023
Hermes Pharma to invest €25 million to bolster manufacturing capabilities
The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing
The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing
NIH’s candidate is based on the Adenovirus 4 backbone, largely used as a vector candidate in HIV and influenza vaccine clinical trials
Honeywell Solstice Air is a hydrofluoroolefin (HFO) propellant in clinical development today for pMDIs
Boostimmune will have access to WuXi XDC's fully integrated one-stop bioconjugate platform
Imaginant offers a unique measurement capability through its PELT coating thickness gauges
Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24
Evonik specializes in mid- to large-scale, later clinical phase HPAPIs
Adding 20,000 liters of installed biologics drug substance manufacturing capacity
The transaction represents an enterprise value of €275 million, an estimated 2023 EV/EBITDA multiple of 18x
Exothera will manufacture Meissa’s MV-012-968 vaccine candidate under CGMP regulations to supply Phase 2 clinical trials
Subscribe To Our Newsletter & Stay Updated
